6-hydroxy Chlorzoxazone is the primary metabolite of Chlorzoxazone in vivo. 6-hydroxy Chlorzoxazone is mainly formed through the hepatic cytochrome P450 enzyme system and is commonly used as a probe in biochemical research to quantitatively evaluate CYP2E1 activity. 6-hydroxy Chlorzoxazone is also involved in studies of hepatic xenobiotic metabolism, pharmacokinetics, and toxicology to elucidate metabolic pathways and drug interaction mechanisms[1-2].
References:
[1] Dreisbach AW, Ferencz N, Hopkins NE, et al. Urinary excretion of 6-hydroxychlorzoxazone as an index of CYP2E1 activity. Clin Pharmacol Ther. 1995 Nov;58(5):498-505.
[2] O'Shea D, Davis SN, Kim RB, et al. Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity. Clin Pharmacol Ther. 1994 Oct;56(4):359-67.
6-hydroxy Chlorzoxazone是Chlorzoxazone在体内的主要代谢产物。6-hydroxy Chlorzoxazone主要通过肝脏细胞色素P450酶系统形成，在生化研究中常作为探针用于定量评估CYP2E1的活性。6-hydroxy Chlorzoxazone参与肝脏异生物代谢、药代动力学及毒理学研究，以阐明代谢途径和药物相互作用机制[1-2]。